Connor Clark & Lunn Investment Management Ltd. Takes $803,000 Position in InfuSystem Holdings, Inc. $INFU

Key Points

• Connor Clark & Lunn acquired 83,207 InfuSystem shares worth approximately $803,000, while institutional investors and hedge funds collectively own 71.13% of the company.
• B. Riley raised its InfuSystem price target to $20 from $12 and maintained a Buy rating; analysts’ consensus is “Moderate Buy” with a $16.67 target.
• InfuSystem shares opened at $12.15, near their one-year high of $12.97. The company also authorized a $20 million share repurchase program covering up to 10.2% of outstanding shares.

Connor Clark & Lunn Investment Management Ltd. acquired a new stake in InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 83,207 shares of the company's stock, valued at approximately $803,000. Connor Clark & Lunn Investment Management Ltd. owned 0.41% of InfuSystem at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of InfuSystem during the 2nd quarter valued at approximately $15,299,000. Minerva Advisors LLC boosted its position in InfuSystem by 5.2% during the 4th quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company's stock valued at $9,676,000 after purchasing an additional 52,942 shares during the period. Vanguard Group Inc. grew its position in shares of InfuSystem by 1.9% during the third quarter. Vanguard Group Inc. now owns 976,177 shares of the company's stock worth $10,113,000 after acquiring an additional 18,539 shares during the last quarter. Punch & Associates Investment Management Inc. increased its stake in shares of InfuSystem by 1.6% in the first quarter. Punch & Associates Investment Management Inc. now owns 837,925 shares of the company's stock valued at $7,734,000 after purchasing an additional 13,175 shares during the period. Finally, Heartland Advisors Inc. bought a new stake in InfuSystem during the 2nd quarter valued at $6,755,000. 71.13% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, B. Riley Financial reaffirmed a "buy" rating and issued a $20.00 price target (up from $12.00) on shares of InfuSystem in a research note on Wednesday, August 5th. Three research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $16.67.

InfuSystem Stock Up 0.9%

Shares of InfuSystem stock opened at $12.15 on Tuesday. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The company has a market cap of $245.21 million, a P/E ratio of 202.53 and a beta of 1.42. The stock has a 50-day moving average price of $10.54 and a 200 day moving average price of $9.71. InfuSystem Holdings, Inc. has a 1 year low of $7.29 and a 1 year high of $12.97.

InfuSystem declared that its Board of Directors has approved a share repurchase plan on Tuesday, May 19th that permits the company to repurchase $20.00 million in shares. This repurchase authorization permits the company to purchase up to 10.2% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's management believes its stock is undervalued.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem's offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.